JP2002535985A - 低下させたバックグラウンドを用いるアッセイ - Google Patents
低下させたバックグラウンドを用いるアッセイInfo
- Publication number
- JP2002535985A JP2002535985A JP2000597417A JP2000597417A JP2002535985A JP 2002535985 A JP2002535985 A JP 2002535985A JP 2000597417 A JP2000597417 A JP 2000597417A JP 2000597417 A JP2000597417 A JP 2000597417A JP 2002535985 A JP2002535985 A JP 2002535985A
- Authority
- JP
- Japan
- Prior art keywords
- analyte
- adenylate kinase
- assay
- atp
- reporter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000003556 assay Methods 0.000 title claims abstract description 91
- 230000002829 reductive effect Effects 0.000 title description 7
- 102000002281 Adenylate kinase Human genes 0.000 claims abstract description 123
- 108020000543 Adenylate kinase Proteins 0.000 claims abstract description 123
- 239000012491 analyte Substances 0.000 claims abstract description 93
- 239000007790 solid phase Substances 0.000 claims abstract description 70
- 239000000203 mixture Substances 0.000 claims abstract description 24
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 14
- 238000006243 chemical reaction Methods 0.000 claims abstract description 12
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 10
- 102000004190 Enzymes Human genes 0.000 claims description 44
- 108090000790 Enzymes Proteins 0.000 claims description 44
- 238000001514 detection method Methods 0.000 claims description 29
- 238000012360 testing method Methods 0.000 claims description 26
- 102000029797 Prion Human genes 0.000 claims description 24
- 108091000054 Prion Proteins 0.000 claims description 24
- 108091006112 ATPases Proteins 0.000 claims description 20
- 102000057290 Adenosine Triphosphatases Human genes 0.000 claims description 20
- 239000005089 Luciferase Substances 0.000 claims description 19
- 108060001084 Luciferase Proteins 0.000 claims description 17
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 claims description 16
- 238000005406 washing Methods 0.000 claims description 16
- 108091000080 Phosphotransferase Proteins 0.000 claims description 15
- 102000020233 phosphotransferase Human genes 0.000 claims description 15
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 claims description 14
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 claims description 14
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 claims description 14
- 244000005700 microbiome Species 0.000 claims description 14
- 239000000758 substrate Substances 0.000 claims description 14
- 238000010438 heat treatment Methods 0.000 claims description 12
- 230000002407 ATP formation Effects 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 239000005556 hormone Substances 0.000 claims description 7
- 229940088597 hormone Drugs 0.000 claims description 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 7
- 230000002779 inactivation Effects 0.000 claims description 5
- 102000001253 Protein Kinase Human genes 0.000 claims description 4
- 239000011230 binding agent Substances 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 108060006633 protein kinase Proteins 0.000 claims description 4
- 239000003053 toxin Substances 0.000 claims description 4
- 231100000765 toxin Toxicity 0.000 claims description 4
- 108700012359 toxins Proteins 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 3
- 239000002207 metabolite Substances 0.000 claims description 3
- 230000002255 enzymatic effect Effects 0.000 claims 1
- 239000000523 sample Substances 0.000 description 61
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 43
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 43
- 238000000034 method Methods 0.000 description 37
- 239000011324 bead Substances 0.000 description 20
- 238000011534 incubation Methods 0.000 description 19
- 238000005415 bioluminescence Methods 0.000 description 16
- 230000029918 bioluminescence Effects 0.000 description 16
- 229940079593 drug Drugs 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 208000010544 human prion disease Diseases 0.000 description 10
- 208000015181 infectious disease Diseases 0.000 description 10
- 102000011923 Thyrotropin Human genes 0.000 description 9
- 108010061174 Thyrotropin Proteins 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 230000035945 sensitivity Effects 0.000 description 9
- 108010007730 Apyrase Proteins 0.000 description 8
- 102000007347 Apyrase Human genes 0.000 description 8
- 208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 description 7
- 230000027455 binding Effects 0.000 description 7
- 230000008878 coupling Effects 0.000 description 7
- 238000010168 coupling process Methods 0.000 description 7
- 238000005859 coupling reaction Methods 0.000 description 7
- MWEQTWJABOLLOS-UHFFFAOYSA-L disodium;[[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-oxidophosphoryl] hydrogen phosphate;trihydrate Chemical compound O.O.O.[Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP([O-])(=O)OP(O)([O-])=O)C(O)C1O MWEQTWJABOLLOS-UHFFFAOYSA-L 0.000 description 7
- 238000003018 immunoassay Methods 0.000 description 7
- 108030001720 Bontoxilysin Proteins 0.000 description 6
- 238000002965 ELISA Methods 0.000 description 6
- 239000012620 biological material Substances 0.000 description 6
- 238000011109 contamination Methods 0.000 description 6
- 230000002458 infectious effect Effects 0.000 description 6
- 239000004816 latex Substances 0.000 description 6
- 229920000126 latex Polymers 0.000 description 6
- 230000009871 nonspecific binding Effects 0.000 description 6
- 208000020406 Creutzfeldt Jacob disease Diseases 0.000 description 5
- 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 description 5
- 102100035172 Glucose-6-phosphate 1-dehydrogenase Human genes 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 229940053031 botulinum toxin Drugs 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000011534 wash buffer Substances 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- 241000701806 Human papillomavirus Species 0.000 description 3
- 241000341655 Human papillomavirus type 16 Species 0.000 description 3
- 206010020850 Hyperthyroidism Diseases 0.000 description 3
- 108010067902 Peptide Library Proteins 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 description 3
- 241000186339 Thermoanaerobacter Species 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000009535 clinical urine test Methods 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- 238000005202 decontamination Methods 0.000 description 3
- 230000003588 decontaminative effect Effects 0.000 description 3
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 3
- 239000002532 enzyme inhibitor Substances 0.000 description 3
- 229940125532 enzyme inhibitor Drugs 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 229940127121 immunoconjugate Drugs 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 241000726121 Acidianus Species 0.000 description 2
- 241000203069 Archaea Species 0.000 description 2
- 241000178334 Caldicellulosiruptor Species 0.000 description 2
- 241000620141 Carboxydothermus Species 0.000 description 2
- 208000005623 Carcinogenesis Diseases 0.000 description 2
- 241000193155 Clostridium botulinum Species 0.000 description 2
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 2
- 108090000331 Firefly luciferases Proteins 0.000 description 2
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 2
- 241000605233 Hydrogenobacter Species 0.000 description 2
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
- 208000009608 Papillomavirus Infections Diseases 0.000 description 2
- 102000013009 Pyruvate Kinase Human genes 0.000 description 2
- 108020005115 Pyruvate Kinase Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000203640 Thermomonospora Species 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 238000003390 bioluminescence detection Methods 0.000 description 2
- 230000036952 cancer formation Effects 0.000 description 2
- 231100000504 carcinogenesis Toxicity 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000003749 cleanliness Effects 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical class O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 231100000676 disease causative agent Toxicity 0.000 description 2
- 229960004242 dronabinol Drugs 0.000 description 2
- 239000002359 drug metabolite Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229940045189 glucose-6-phosphate Drugs 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- 239000012678 infectious agent Substances 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 238000004020 luminiscence type Methods 0.000 description 2
- 229910001425 magnesium ion Inorganic materials 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 239000002751 oligonucleotide probe Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- JWDFQMWEFLOOED-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(pyridin-2-yldisulfanyl)propanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCSSC1=CC=CC=N1 JWDFQMWEFLOOED-UHFFFAOYSA-N 0.000 description 1
- YOVRGSHRZRJTLZ-HZPDHXFCSA-N 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol Chemical compound C1=C(C(O)=O)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 YOVRGSHRZRJTLZ-HZPDHXFCSA-N 0.000 description 1
- VYMHBQQZUYHXSS-UHFFFAOYSA-N 2-(3h-dithiol-3-yl)pyridine Chemical compound C1=CSSC1C1=CC=CC=N1 VYMHBQQZUYHXSS-UHFFFAOYSA-N 0.000 description 1
- 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 1
- 102000055025 Adenosine deaminases Human genes 0.000 description 1
- 229940093764 Adenylate kinase inhibitor Drugs 0.000 description 1
- 241000567147 Aeropyrum Species 0.000 description 1
- 241001147780 Alicyclobacillus Species 0.000 description 1
- 241000147157 Ammonifex Species 0.000 description 1
- 241000207208 Aquifex Species 0.000 description 1
- 241000205046 Archaeoglobus Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000003508 Botulism Diseases 0.000 description 1
- 241000178972 Caloramator Species 0.000 description 1
- 241000218236 Cannabis Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000008697 Cannabis sativa Nutrition 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 241000192733 Chloroflexus Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241000971513 Coprothermobacter Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- XXGMIHXASFDFSM-UHFFFAOYSA-N Delta9-tetrahydrocannabinol Natural products CCCCCc1cc2OC(C)(C)C3CCC(=CC3c2c(O)c1O)C XXGMIHXASFDFSM-UHFFFAOYSA-N 0.000 description 1
- 241000205236 Desulfurococcus Species 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 241001331845 Equus asinus x caballus Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000531184 Ferroglobus Species 0.000 description 1
- 241000206212 Fervidobacterium Species 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 241001135645 Geotoga Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000005548 Hexokinase Human genes 0.000 description 1
- 108700040460 Hexokinases Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000531259 Hyperthermus Species 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- 241000921347 Meiothermus Species 0.000 description 1
- 241000134732 Metallosphaera Species 0.000 description 1
- 241000202974 Methanobacterium Species 0.000 description 1
- 241000203407 Methanocaldococcus jannaschii Species 0.000 description 1
- 241000203353 Methanococcus Species 0.000 description 1
- 241000204675 Methanopyrus Species 0.000 description 1
- 241000202997 Methanothermus Species 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241001135648 Petrotoga Species 0.000 description 1
- BJGNCJDXODQBOB-SSDOTTSWSA-N Photinus luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-SSDOTTSWSA-N 0.000 description 1
- 241000204826 Picrophilus Species 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 208000024777 Prion disease Diseases 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 241000205226 Pyrobaculum Species 0.000 description 1
- 241000205160 Pyrococcus Species 0.000 description 1
- 241000204671 Pyrodictium Species 0.000 description 1
- 241000531151 Pyrolobus Species 0.000 description 1
- 241001148569 Rhodothermus Species 0.000 description 1
- 241000144007 Rubrobacter Species 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 101000757617 Solanum tuberosum Apyrase Proteins 0.000 description 1
- 241000205219 Staphylothermus Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 241000508776 Stetteria Species 0.000 description 1
- 241000132988 Stygiolobus Species 0.000 description 1
- 241000205101 Sulfolobus Species 0.000 description 1
- 241000520811 Sulfophobococcus Species 0.000 description 1
- 241000203775 Thermoactinomyces Species 0.000 description 1
- 241001137870 Thermoanaerobacterium Species 0.000 description 1
- 241001647802 Thermobifida Species 0.000 description 1
- 241001331078 Thermobispora Species 0.000 description 1
- 241001626433 Thermobrachium Species 0.000 description 1
- 241001655242 Thermochromatium Species 0.000 description 1
- 241000205188 Thermococcus Species 0.000 description 1
- 241001524191 Thermocrispum Species 0.000 description 1
- 241000205174 Thermofilum Species 0.000 description 1
- 241000317520 Thermohydrogenium Species 0.000 description 1
- 241000588679 Thermomicrobium Species 0.000 description 1
- 241000204667 Thermoplasma Species 0.000 description 1
- 241001133165 Thermopolyspora Species 0.000 description 1
- 241000205204 Thermoproteus Species 0.000 description 1
- 241000531141 Thermosphaera Species 0.000 description 1
- 241000531079 Thermosyntropha Species 0.000 description 1
- 241000204652 Thermotoga Species 0.000 description 1
- 241000589596 Thermus Species 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 208000018756 Variant Creutzfeldt-Jakob disease Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000004198 anterior pituitary gland Anatomy 0.000 description 1
- 238000007486 appendectomy Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 231100001103 botulinum neurotoxin Toxicity 0.000 description 1
- 208000005881 bovine spongiform encephalopathy Diseases 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000004534 cecum Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- LIYGYAHYXQDGEP-UHFFFAOYSA-N firefly oxyluciferin Natural products Oc1csc(n1)-c1nc2ccc(O)cc2s1 LIYGYAHYXQDGEP-UHFFFAOYSA-N 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 201000011424 foodborne botulism Diseases 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000003505 heat denaturation Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000000642 iatrogenic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- JJVOROULKOMTKG-UHFFFAOYSA-N oxidized Photinus luciferin Chemical compound S1C2=CC(O)=CC=C2N=C1C1=NC(=O)CS1 JJVOROULKOMTKG-UHFFFAOYSA-N 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 238000009595 pap smear Methods 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920006380 polyphenylene oxide Polymers 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 208000008864 scrapie Diseases 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000012414 sterilization procedure Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 238000007483 tonsillectomy Methods 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25125—Digestion or removing interfering materials
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
- Refinement Of Pig-Iron, Manufacture Of Cast Iron, And Steel Manufacture Other Than In Revolving Furnaces (AREA)
- Developing Agents For Electrophotography (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9902659.3 | 1999-02-05 | ||
| GBGB9902659.3A GB9902659D0 (en) | 1999-02-05 | 1999-02-05 | Assay with reduced background |
| PCT/GB2000/000315 WO2000046357A1 (en) | 1999-02-05 | 2000-02-03 | Assay with reduced background |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002535985A true JP2002535985A (ja) | 2002-10-29 |
| JP2002535985A5 JP2002535985A5 (enExample) | 2007-04-19 |
Family
ID=10847233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000597417A Pending JP2002535985A (ja) | 1999-02-05 | 2000-02-03 | 低下させたバックグラウンドを用いるアッセイ |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US6913896B1 (enExample) |
| EP (1) | EP1151087B1 (enExample) |
| JP (1) | JP2002535985A (enExample) |
| AT (1) | ATE394478T1 (enExample) |
| AU (1) | AU774580B2 (enExample) |
| CA (1) | CA2360779C (enExample) |
| DE (1) | DE60038788D1 (enExample) |
| DK (1) | DK1151087T3 (enExample) |
| ES (1) | ES2304940T3 (enExample) |
| GB (1) | GB9902659D0 (enExample) |
| PT (1) | PT1151087E (enExample) |
| WO (1) | WO2000046357A1 (enExample) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011512151A (ja) * | 2008-02-20 | 2011-04-21 | ヘルス プロテクション エージェンシー | 汚染除去プロセス検証のための共有結合熱安定性キナーゼ |
| JP2011211919A (ja) * | 2010-03-31 | 2011-10-27 | Aquas Corp | 微生物活性の評価方法、および、該評価方法を用いる水系の微生物制御方法 |
| JP2011528906A (ja) * | 2008-07-22 | 2011-12-01 | プロメガ・コーポレーション | Ａｄｐ検出に基づく発光ホスホトランスフェラーゼまたはａｔｐヒドロラーゼのアッセイ法 |
| JP2012514453A (ja) * | 2009-01-07 | 2012-06-28 | ヘルス プロテクション エージェンシー | 高速生物発光検出システム |
| JPWO2021241446A1 (enExample) * | 2020-05-25 | 2021-12-02 |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6824997B1 (en) | 1998-09-18 | 2004-11-30 | Binax, Inc. | Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies |
| US9134303B1 (en) | 1998-08-25 | 2015-09-15 | Alere Scarborough, Inc. | ICT immunoassay for Legionella pneumophila serogroup 1 antigen employing affinity purified antibodies thereto |
| US20080096236A1 (en) * | 1998-08-25 | 2008-04-24 | Binax, Inc. | Method for Detecting the Presence of Target Bacteria or a Target Component Carbohydrate Antigen Thereof |
| GB9902659D0 (en) * | 1999-02-05 | 1999-03-31 | Microbiological Res Authority | Assay with reduced background |
| DE10107083C2 (de) * | 2001-02-13 | 2003-02-20 | Abdulgabar Salama | Pentosan Polysulfat als Ligand zum Nachweis von Prionen |
| GB0406427D0 (en) * | 2004-03-22 | 2004-04-21 | Health Prot Agency | Biological indicator |
| GB0508981D0 (en) * | 2005-05-03 | 2005-06-08 | Acolyte Biomedica Ltd | Distinguishing cells in a sample |
| WO2007123345A1 (en) * | 2006-04-21 | 2007-11-01 | Peoplebio, Inc. | Method for differentially detecting multimeric form from monomeric form of multimer-forming polypeptides through three-dimensional interactions |
| US10466245B2 (en) | 2008-02-20 | 2019-11-05 | The Secretary Of State For Health | Covalently linked thermostable kinase for decontamination process validation |
| WO2010062711A1 (en) * | 2008-11-03 | 2010-06-03 | Cytosignet, Inc. | Determining immunoglobulins in non-blood body fluids of neonatal ungulates |
| GB0918016D0 (en) * | 2009-10-14 | 2009-12-02 | Univ Portsmouth | Biosensor |
| WO2012170998A1 (en) * | 2011-06-10 | 2012-12-13 | Cornell University | Immobilized protein system for rapid and enhanced multiplexed diagnostics |
| GB201115911D0 (en) | 2011-09-14 | 2011-10-26 | Health Prot Agency | Thermostable assay reagents |
| JP5882177B2 (ja) * | 2012-10-19 | 2016-03-09 | 株式会社日立製作所 | 生体物質回収方法及び生体物質回収装置 |
| EP3462174B1 (en) | 2013-03-15 | 2021-12-29 | Arizona Board of Regents on behalf of Arizona State University | Biosensor microarray compositions and methods |
| US10179930B2 (en) | 2014-02-06 | 2019-01-15 | Scanogen Inc. | Detection units and methods for detecting a target analyte |
| US20170231539A1 (en) * | 2014-08-15 | 2017-08-17 | Hoope Technologies Corporation | Devices and methods for fluid sample collection and diagnostic testing |
| JP6510041B2 (ja) | 2014-10-08 | 2019-05-08 | プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ | 生物発光サクシネート検出アッセイ |
| US9107906B1 (en) | 2014-10-28 | 2015-08-18 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
| US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
| US11371986B2 (en) | 2018-05-25 | 2022-06-28 | Scanogen Inc. | Detection units and methods for detecting a target analyte |
| US20230242965A1 (en) * | 2020-05-28 | 2023-08-03 | Charm Sciences, Inc. | Methods and assemblies for sample analysis |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08501446A (ja) * | 1992-09-22 | 1996-02-20 | ラムダテク エス．アー． | 生物学的化合物の検出及び／または測定用結合体 |
| JPH10502815A (ja) * | 1994-07-13 | 1998-03-17 | イギリス国 | 捕捉アッセイ |
| JP2000500005A (ja) * | 1995-09-14 | 2000-01-11 | ザ レジェンツ オブ ザ ユニバーシティー オブ カリフォルニア | 天然ＰｒＰ▲上Ｓｃ▼特異的抗体 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4014745A (en) * | 1975-04-30 | 1977-03-29 | Nasa | Application of luciferase assay for ATP to antimicrobial drug susceptibility |
| GB1567606A (en) * | 1976-08-24 | 1980-05-21 | Secr Defence | Glycerokinases |
| US4160817A (en) * | 1976-09-29 | 1979-07-10 | Research Corporation | Application of protein-protein interaction as an assay for the detection of cancer |
| US4446231A (en) * | 1979-10-03 | 1984-05-01 | Self Colin H | Immunoassay using an amplified cyclic detection system |
| CA1173768A (en) | 1980-10-09 | 1984-09-04 | Kazuhiko Nagata | Adenylate kinase and process for the production thereof |
| US4752562A (en) * | 1981-01-23 | 1988-06-21 | Baxter Travenol Laboratories, Inc. | Detection of serum antibody and surface antigen by radial partition immunoassay |
| JPS58155099A (ja) | 1982-03-12 | 1983-09-14 | Unitika Ltd | コリンエステラ−ゼ定量用試薬 |
| US4628031A (en) * | 1984-09-18 | 1986-12-09 | Michigan Biotechnology Institute | Thermostable starch converting enzymes |
| US4656128A (en) | 1985-01-22 | 1987-04-07 | Research Corporation | Modified alkaline phosphatase |
| EP0304934A3 (de) | 1987-08-26 | 1989-07-26 | Hunger, Hans-Dieter | Markierte molekulare Sonden, Verfahren zu ihrer Herstellung und ihre Verwendung |
| US4855241A (en) * | 1988-05-26 | 1989-08-08 | Washington University | Tumor diagnostic method |
| US5366871A (en) * | 1991-11-13 | 1994-11-22 | The University Of Utah | Ubiquitin-peptide extensions as enzyme substrates |
| US5395752A (en) * | 1993-03-19 | 1995-03-07 | Ciba Corning Diagnostics Corp. | Long emission wavelength chemiluminescent compounds and their use in test assays |
| US5962637A (en) * | 1994-06-03 | 1999-10-05 | Microbiological Research Authority | Toxin assay |
| US5733541A (en) * | 1995-04-21 | 1998-03-31 | The Regent Of The University Of Michigan | Hematopoietic cells: compositions and methods |
| US6150172A (en) * | 1999-01-08 | 2000-11-21 | The United States Of America As Represented By The Secretary Of Agriculture | Method and kit for extracting prion protein |
| GB9902659D0 (en) * | 1999-02-05 | 1999-03-31 | Microbiological Res Authority | Assay with reduced background |
-
1999
- 1999-02-05 GB GBGB9902659.3A patent/GB9902659D0/en not_active Ceased
-
2000
- 2000-02-03 JP JP2000597417A patent/JP2002535985A/ja active Pending
- 2000-02-03 DE DE60038788T patent/DE60038788D1/de not_active Expired - Lifetime
- 2000-02-03 PT PT00901771T patent/PT1151087E/pt unknown
- 2000-02-03 ES ES00901771T patent/ES2304940T3/es not_active Expired - Lifetime
- 2000-02-03 DK DK00901771T patent/DK1151087T3/da active
- 2000-02-03 CA CA2360779A patent/CA2360779C/en not_active Expired - Lifetime
- 2000-02-03 WO PCT/GB2000/000315 patent/WO2000046357A1/en not_active Ceased
- 2000-02-03 AT AT00901771T patent/ATE394478T1/de active
- 2000-02-03 US US09/889,520 patent/US6913896B1/en not_active Expired - Lifetime
- 2000-02-03 AU AU23071/00A patent/AU774580B2/en not_active Expired
- 2000-02-03 EP EP00901771A patent/EP1151087B1/en not_active Expired - Lifetime
-
2005
- 2005-02-25 US US11/065,700 patent/US20050208608A1/en not_active Abandoned
-
2008
- 2008-10-14 US US12/285,766 patent/US20090186368A1/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08501446A (ja) * | 1992-09-22 | 1996-02-20 | ラムダテク エス．アー． | 生物学的化合物の検出及び／または測定用結合体 |
| JPH10502815A (ja) * | 1994-07-13 | 1998-03-17 | イギリス国 | 捕捉アッセイ |
| JP2000500005A (ja) * | 1995-09-14 | 2000-01-11 | ザ レジェンツ オブ ザ ユニバーシティー オブ カリフォルニア | 天然ＰｒＰ▲上Ｓｃ▼特異的抗体 |
Non-Patent Citations (3)
| Title |
|---|
| JPN6009056931, Ａｎａｌｙｔｉｃａｌ Ｂｉｏｃｈｅｍｉｓｔｒｙ, 1993, Ｖｏｌ． ２１５, ｐｐ．３０２−３０４ * |
| JPN6009056932, Ａｒｃｈ． Ｂｉｏｃｈｅｍ． Ｂｉｏｐｈｙｓ．, 1996, Ｖｏｌ． ３３３, ｐｐ．７５−８４ * |
| JPN6009056934, Ｊ． Ｍｏｌ． Ｂｉｏｌ．, 1992, Ｖｏｌ． ２２８, ｐｐ．２６５−２７６ * |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011512151A (ja) * | 2008-02-20 | 2011-04-21 | ヘルス プロテクション エージェンシー | 汚染除去プロセス検証のための共有結合熱安定性キナーゼ |
| JP2011528906A (ja) * | 2008-07-22 | 2011-12-01 | プロメガ・コーポレーション | Ａｄｐ検出に基づく発光ホスホトランスフェラーゼまたはａｔｐヒドロラーゼのアッセイ法 |
| JP2012514453A (ja) * | 2009-01-07 | 2012-06-28 | ヘルス プロテクション エージェンシー | 高速生物発光検出システム |
| JP2011211919A (ja) * | 2010-03-31 | 2011-10-27 | Aquas Corp | 微生物活性の評価方法、および、該評価方法を用いる水系の微生物制御方法 |
| JPWO2021241446A1 (enExample) * | 2020-05-25 | 2021-12-02 | ||
| WO2021241446A1 (ja) * | 2020-05-25 | 2021-12-02 | 横河電機株式会社 | 検体中の標的分子の検出方法、及び標的分子検出キット |
| KR20220167333A (ko) * | 2020-05-25 | 2022-12-20 | 요코가와 덴키 가부시키가이샤 | 검체 중의 표적 분자의 검출 방법, 및 표적 분자 검출 키트 |
| JP7226651B2 (ja) | 2020-05-25 | 2023-02-21 | 横河電機株式会社 | 検体中の標的分子の検出方法、及び標的分子検出キット |
| KR102833537B1 (ko) | 2020-05-25 | 2025-07-11 | 요코가와 덴키 가부시키가이샤 | 검체 중의 표적 분자의 검출 방법, 및 표적 분자 검출 키트 |
Also Published As
| Publication number | Publication date |
|---|---|
| DK1151087T3 (da) | 2008-08-04 |
| GB9902659D0 (en) | 1999-03-31 |
| CA2360779A1 (en) | 2000-08-10 |
| AU774580B2 (en) | 2004-07-01 |
| CA2360779C (en) | 2010-04-27 |
| PT1151087E (pt) | 2008-08-11 |
| WO2000046357A1 (en) | 2000-08-10 |
| US20090186368A1 (en) | 2009-07-23 |
| US6913896B1 (en) | 2005-07-05 |
| ATE394478T1 (de) | 2008-05-15 |
| AU2307100A (en) | 2000-08-25 |
| EP1151087B1 (en) | 2008-05-07 |
| EP1151087A1 (en) | 2001-11-07 |
| DE60038788D1 (de) | 2008-06-19 |
| US20050208608A1 (en) | 2005-09-22 |
| ES2304940T3 (es) | 2008-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1151087B1 (en) | Assay with reduced background | |
| Song et al. | Direct detection of bacterial genomic DNA at sub-femtomolar concentrations using single molecule arrays | |
| Niemeyer et al. | Detecting antigens by quantitative immuno-PCR | |
| US9102976B2 (en) | Biological indicator | |
| Mole et al. | Phage as a diagnostic–the use of phage in TB diagnosis | |
| CA2373160C (en) | Methods for monitoring eukaryotic cell integrity, growth and/or division | |
| US9046523B2 (en) | Rapid bioluminescence detection system | |
| JP2761159B2 (ja) | 相補的核酸配列の検出方法及びそのためのキット | |
| JP2020533974A (ja) | 呼吸器合胞体ウイルス種のニッキング及び伸長増幅反応（ｎｅａｒ） | |
| JPH08289780A (ja) | 微生物等の検出方法、この検出方法に用いる抗体、及びこの抗体を産生する新規ハイブリドーマ | |
| Murdoch | Development of a Novel Ultra-Sensitive Immunoassay for the Detection of Prion Protein on Surgical Instruments | |
| HK1097576B (en) | Biological indicator | |
| JP2007192630A (ja) | 高感度酵素免疫測定方法およびこの方法を利用するタンパク質の超高感度測定法 | |
| Bacilli | The Journal of Laboratory and Clinical M | |
| JP2004069491A (ja) | 薬物代謝酵素活性の測定方法、並びに薬物代謝酵素の活性阻害の評価方法、およびそれらの方法のための組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20040324 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070131 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070131 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20081009 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091110 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100209 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100727 |